142 related articles for article (PubMed ID: 36344907)
21. Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome.
Taja-Chayeb L; Vidal-Millán S; Gutiérrez-Hernández O; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; de la Cruz-Hernández E; Dueñas-González A
World J Surg Oncol; 2009 Dec; 7():97. PubMed ID: 20017945
[TBL] [Abstract][Full Text] [Related]
22. Cancer surveillance for individuals with Li-Fraumeni syndrome.
Kratz CP; Villani A; Nichols KE; Schiffman J; Malkin D
Eur J Hum Genet; 2020 Nov; 28(11):1481-1482. PubMed ID: 32814850
[No Abstract] [Full Text] [Related]
23. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
Bougeard G; Limacher JM; Martin C; Charbonnier F; Killian A; Delattre O; Longy M; Jonveaux P; Fricker JP; Stoppa-Lyonnet D; Flaman JM; Frébourg T
J Med Genet; 2001 Apr; 38(4):253-7. PubMed ID: 11370630
[No Abstract] [Full Text] [Related]
24. EGFR-mutated lung cancer in Li-Fraumeni syndrome.
Michalarea V; Calcasola M; Cane P; Tobal K; Izatt L; Spicer J
Lung Cancer; 2014 Sep; 85(3):485-7. PubMed ID: 25047674
[TBL] [Abstract][Full Text] [Related]
25. Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature.
Baek YS; Seo JY; Song JY; Lee SY; Kim A; Jeon J
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e174-e175. PubMed ID: 30653764
[No Abstract] [Full Text] [Related]
26. [TP53 germline mutation related Li-Fraumeni syndrome: report of a case].
Liu XL; Jin XF; Song YL; Li GQ; Lin DL; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):458-460. PubMed ID: 35511646
[TBL] [Abstract][Full Text] [Related]
27. Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation.
Castiaux J; Vandernoot I; Dallemagne J; Bruneau M; Delaunoy M; Peyrassol X; Heimann P; De Wilde V; Wolfromm A
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e645-e648. PubMed ID: 34049842
[No Abstract] [Full Text] [Related]
28. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.
Andrade RC; de Lima MAFD; de Faria PAS; Vargas FR
Fam Cancer; 2018 Jan; 17(1):119-122. PubMed ID: 28477317
[TBL] [Abstract][Full Text] [Related]
29. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
[TBL] [Abstract][Full Text] [Related]
30. Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
Hatton JN; Sargen MR; Frone MN; de Andrade KC; Savage SA; Khincha PP
J Invest Dermatol; 2022 Sep; 142(9):2534-2537.e1. PubMed ID: 35183552
[No Abstract] [Full Text] [Related]
31. Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs*12.
Takahashi S; Shimazu K; Kodama K; Fukuda K; Yoshida T; Taguchi D; Takahashi T; Nanjyo H; Shibata H
Jpn J Clin Oncol; 2020 Sep; 50(10):1214-1217. PubMed ID: 32577752
[TBL] [Abstract][Full Text] [Related]
32. Rare IDH1 variants are common in pediatric hemispheric diffuse astrocytomas and frequently associated with Li-Fraumeni syndrome.
Sumerauer D; Krskova L; Vicha A; Misove A; Mamatjan Y; Jencova P; Vlckova M; Slamova L; Vanova K; Liby P; Taborsky J; Koblizek M; Klubal R; Kyncl M; Zadeh G; Stary J; Zamecnik J; Ramaswamy V; Zapotocky M
Acta Neuropathol; 2020 Apr; 139(4):795-797. PubMed ID: 31897644
[No Abstract] [Full Text] [Related]
33. Characterization of cutaneous fibrohistiocytic tumors associated with Li-Fraumeni syndrome: a retrospective single-center study and review of the literature.
Hobayan CGP; Roman J; Kaffenberger BH; Chung CG
Int J Dermatol; 2023 Sep; 62(9):e498-e500. PubMed ID: 37042442
[No Abstract] [Full Text] [Related]
34. A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
Varley JM; McGown G; Thorncroft M; White GR; Tricker KJ; Kelsey AM; Birch JM; Evans DG
Br J Cancer; 1998 Oct; 78(8):1081-3. PubMed ID: 9792154
[TBL] [Abstract][Full Text] [Related]
35. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
Upton B; Chu Q; Li BD
Surg Oncol Clin N Am; 2009 Jan; 18(1):145-56, ix. PubMed ID: 19056046
[TBL] [Abstract][Full Text] [Related]
36. Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
Klein JD; Kupferman ME
Head Neck; 2017 Feb; 39(2):E20-E22. PubMed ID: 27726232
[TBL] [Abstract][Full Text] [Related]
37. Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study.
Struewe FJ; Schott S; de Zwaan M; Kratz CP
Fam Cancer; 2023 Oct; 22(4):495-497. PubMed ID: 37351819
[No Abstract] [Full Text] [Related]
38. Hematologic malignancies and Li-Fraumeni syndrome.
Swaminathan M; Bannon SA; Routbort M; Naqvi K; Kadia TM; Takahashi K; Alvarado Y; Ravandi-Kashani F; Patel KP; Champlin R; Kantarjian H; Strong L; DiNardo CD
Cold Spring Harb Mol Case Stud; 2019 Feb; 5(1):. PubMed ID: 30709875
[TBL] [Abstract][Full Text] [Related]
39. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Kamihara J; Rana HQ; Garber JE
Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
